Concepedia

Author

Mir Lim

The University of Texas Southwestern Medical CenterORCID

Also Known As

Mir Lim

46

Publications

265

Citations

9

H-Index

8

Concepts

All Affiliations

The University of Texas Southwestern Medical CenterNational Yang Ming Chiao Tung UniversityTaipei Veterans General HospitalHarvard UniversityGuardant (United States)
ML

About

Mir Lim is an author at The University of Texas Southwestern Medical Center specializing in hepatology, radiation oncology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

104

2

Hepatology

2

2

104

3

Immunology

2

2

104

4

Pathology

2

2

104

5

Cancer Therapeutics

1

1

56

Mir Lim

×

8

Publications

224

Citations

8

H-Index

YearCitations

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen,

JHEP Reports

2022

56

Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150

Magdalena Espinoza, Maishara Muquith, Mir Lim,

Gastroenterology

2023

48

Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center

Mir Lim, David S. Shulman, Holly Roberts,

Cancer Medicine

2020

35

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Stephanie Alden, Mir Lim, Chester Kao,

Cancer Research Communications

2023

29

Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma

Mir Lim, Maishara Muquith, Bernadette Miramontes,

Hepatology

2023

21

Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

David Hsiehchen, Leslie Bucheit, Dong Yang,

Nature Communications

2022

14

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma

Joseph W. Franses, Mir Lim, Adam M. Burgoyne,

The Oncologist

2022

11

Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma

Mir Lim, Magdalena Espinoza, Yi‐Hsiang Huang,

JAMA Network Open

2025

10

Page 1